Ibaraki, Japan

Ryoichi Oshiumi


Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 73(Granted Patents)


Location History:

  • Ibaragi, JP (1987)
  • Ibaraki, JP (1982 - 1989)

Company Filing History:


Years Active: 1982-1989

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ryoichi Oshiumi: Innovator in Radiation Sensitizers and Reactive Polymers

Introduction

Ryoichi Oshiumi is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of radiation sensitizers and reactive polymers. With a total of 3 patents to his name, Oshiumi's work has the potential to impact medical treatments and materials science.

Latest Patents

Oshiumi's latest patents include a radiation sensitizer that contains a specific nitrotriazole compound as an active ingredient. This invention accelerates the inactivation of intractable hypoxic cells in malignant tumors through irradiation. Another significant patent is for a method of manufacturing a reactive polymer. This method involves the reaction of a polymer containing a free carboxylic group with an unsaturated aziridine compound, resulting in a reactive polymer that can be utilized in various applications.

Career Highlights

Throughout his career, Ryoichi Oshiumi has worked with prominent companies such as Nippon Shokubai Kagaku Kogyo Co., Ltd. and Adeka Argus Chemical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to innovative projects in the chemical industry.

Collaborations

Oshiumi has collaborated with notable colleagues, including Shuzo Fukuchi and Tetsuzo Hayashi. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Ryoichi Oshiumi stands out as an influential inventor in the fields of radiation sensitizers and reactive polymers. His patents reflect a commitment to advancing technology that can have significant implications for both medical and industrial applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…